Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
The Journal of General Virology|February 1, 1994
Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infectionM Buisson, P Morand, O Genoulaz, et al.
Leukemia|February 20, 1999
Development of an Epstein-Barr virus type 2 (EBV-2)-associated hepatic B cell non-Hodgkin's lymphoma in an HIV-1-infected patient following a change in the EBV dominant typeM Buisson, P Morand, M Peoc'h, et al.
Pathologie-Biologie|May 1, 1987
[Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases]J B Dureux, P Canton, P Chavanet, et al.
Medecine Et Maladies Infectieuses|April 18, 2018
Vitamin D supplementation, bone turnover, and inflammation in HIV-infected patientsL Benguella, A Arbault, A Fillion, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2019
Efficacy of Bacteriophages in a Staphylococcus aureus Nondiabetic or Diabetic Foot Infection Murine ModelS Albac, M Medina, D Labrousse, et al.
Diagnostic and Interventional Imaging|July 21, 2019
PICC management led by technicians: Establishment of a cooperation program with radiologists and evaluation of complicationsV Chasseigne, A Larbi, J Goupil, et al.
International Journal of Cancer|July 3, 1998
Different distribution of H1-H2 Epstein-Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from AlgeriaM Bouzid, W Sheng, M Buisson, et al.
Epidemiology and Infection|January 15, 2011
A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patientsL Piroth, I Fournel, S Mahy, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 16, 2007
Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatmentE Pukenyte, F X Lescure, D Rey, et al.
Nucleic Acids Research|March 25, 1991
Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are requiredJ F Giot, I Mikaelian, M Buisson, et al.
Pageof 15